Acceptance-based therapy: the potential to augment behavioral interventions in the treatment of type 2 diabetes
Overview
This narrative review discusses how acceptance-based therapies (ABTs), including techniques from acceptance and commitment therapy, may augment standard behavioral interventions for type 2 diabetes management. The resource outlines the role of lifestyle changes and medication adherence in diabetes treatment while proposing ABTs as a potential novel option. It notes that further research and long-term randomized controlled trials are needed to clarify the feasibility and effectiveness of this approach.
- ID
a6f8bd7202f141a4- Source org
- OpenAlex
- Author
- Michelle I. Cardel (University of Florida Health), Kathryn M. Ross (University of Florida Health), Meghan L. Butryn (Drexel University), William T. Donahoo (University of Florida), Abraham Eastman (University of Florida Health), Julia Dillard (University of Florida), Anna H. Grummon, Patrick Hopkins (The University of Texas at El Paso), Leah D. Whigham (The University of Texas Health Science Center at Houston), David M. Janicke (University of Florida Health)
- Published
- 2020-01-21
- OA status
- gold
- DOI
- 10.1038/s41387-020-0106-9
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- 18
Tags
Verification
- identityok via crossref · score 1 · checked_at unknown
- legitimacykeep via unknown · score 0.95 · checked_at unknown
- linkok via http-check · 2026-07-21T15:52:31.592259+00:00
Cite this entry
BibTeX
@article{allodium:a6f8bd7202f141a4,
title = {Acceptance-based therapy: the potential to augment behavioral interventions in the treatment of type 2 diabetes},
author = {Michelle I. Cardel and Kathryn M. Ross and Meghan L. Butryn and William T. Donahoo and Abraham Eastman and Julia Dillard and Anna H. Grummon and Patrick Hopkins and Leah D. Whigham and David M. Janicke},
year = {2020},
journal = {OpenAlex},
doi = {10.1038/s41387-020-0106-9},
url = {https://doi.org/10.1038/s41387-020-0106-9}
}RIS
TY - JOUR TI - Acceptance-based therapy: the potential to augment behavioral interventions in the treatment of type 2 diabetes AU - Cardel, Michelle I. AU - Ross, Kathryn M. AU - Butryn, Meghan L. AU - Donahoo, William T. AU - Eastman, Abraham AU - Dillard, Julia AU - Grummon, Anna H. AU - Hopkins, Patrick AU - Whigham, Leah D. AU - Janicke, David M. PY - 2020 PB - OpenAlex DO - 10.1038/s41387-020-0106-9 UR - https://doi.org/10.1038/s41387-020-0106-9 ER -
APA
Cardel, M. I., Ross, K. M., Butryn, M. L., Donahoo, W. T., Eastman, A., Dillard, J., Grummon, A. H., Hopkins, P., Whigham, L. D., & Janicke, D. M. (2020). Acceptance-based therapy: the potential to augment behavioral interventions in the treatment of type 2 diabetes. OpenAlex. https://doi.org/10.1038/s41387-020-0106-9
Related entries
- Efficacy of acceptance and commitment therapy for people with type 2 diabetes: Systematic review and meta‐analysis
- A Randomized Controlled Trial of Acceptance and Commitment Therapy for Type 2 Diabetes Management: The Moderating Role of Coping Styles
- The effectiveness of acceptance and commitment therapy on the self-care and adherence to treatment in patients with type 2 diabetes
- Effectiveness of acceptance and commitment therapy in people with type 2 diabetes mellitus: A systematic review and meta‐analysis
- The Effectiveness of Acceptance and Commitment Therapy on Quality of Life among Patients with Type 2 Diabetes
- Acceptance and Commitment Based Therapy on Disease Perception and Psychological Capital in Patients with Type II Diabetes
- Proposing an Acceptance and Commitment Therapy intervention to promote improved diabetes management in adolescents: A treatment conceptualization.
- A randomised wait-list controlled clinical trial of the effects of acceptance and commitment therapy in patients with type 1 diabetes: a study protocol
- The Role of Acceptance and Commitment Therapy in Cardiovascular and Diabetes Healthcare: A Scoping Review
- ACTonDiabetes—a guided psychological internet intervention based on Acceptance and Commitment Therapy (ACT) for adults living with type 1 or 2 diabetes: results of a randomised controlled feasibility trial